Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Your Article Summary
See Latest ArticlesGuidelines for the diagnosis and treatment of dermatitis herpetiformis
Journal of the European Academy of Dermatology and Venereology, 06/01/09
Caproni M et al. - Dermatitis herpetiformis is a rare disease that should be considered the cutaneous expression of a gluten-sensitive enteropathy indistinguishable from celiac disease. The diagnosis of dermatitis herpetiformis is established clinically, histologically, immunopathologically and serologically. A gluten-free diet (GFD) is the treatment of choice for patients with dermatitis herpetiformis. Dapsone and/or other drugs should be used during the period until the GFD is effective.
Related Articles
Fibrillar IgA deposition in dermatitis herpetiformis - an underreported pattern with potential clinical significance
Journal of Cutaneous Pathology, 11/18/09
Relevance Score: 68%
Eotaxin (CCL11), TARC [thymus and activation-regulated chemokine (CCL17)], MCP-1 (CCL2) and CCR-1, CXCR-1, CXCR-2 expression in dermatitis herpetiformis and bullous pemphigoid
Archives of Medical Science, 11/03/09
Relevance Score: 64%
Prediction of Clinical and Mucosal Severity of Coeliac Disease and Dermatitis Herpetiformis by Quantification of IgA/IgG Serum Antibodies to Tissue Transglutaminase
Journal of Pediatric Gastroenterology and Nutrition, 10/20/09
Relevance Score: 64%
Linear immunoglobulin A bullous dermatosis
Expert Review of Dermatology, 10/14/09
Relevance Score: 64%
Dapsone hypersensitivity syndrome with circulating 190-kDa and 230-kDa autoantibodies
Clinical and Experimental Dermatology, 10/07/09
Relevance Score: 64%
Today in Dermatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Radiofrequency Ablation of Facial Nerve Branches Controlling Glabellar Frowning
Dermatologic Surgery, 12/10/09
Muscle Weakness After Repeated Injection of Botulinum Toxin Type A Evaluated According to Bite Force Measurement of Human Masseter Muscle
Dermatologic Surgery, 12/10/09
Randomized, Placebo-Controlled Study of a New Botulinum Toxin Type A for Treatment of Glabellar Lines: Efficacy and Safety
Dermatologic Surgery, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor